Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1

References

Arbour, N., Day, R., Newcombe, J., and Talbot, P.J. (2000). Neuroinvasion by human respiratory coronaviruses. J. Virol. 74: 8913–8921, https://doi.org/10.1128/jvi.74.19.8913-8921.2000.Search in Google Scholar PubMed PubMed Central

Barnes, B.J., Adrover, J.M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J.M., Dassler-Plenker, J., Guerci, P., Huynh, C., Knight, J.S., et al.. (2020). Targeting potential drivers of COVID-19: neutrophil extracellular traps. J. Exp. Med. 217: e20200652, https://doi.org/10.1084/jem.20200652.Search in Google Scholar PubMed PubMed Central

Beazley-Long, N., Hua, J., Jehle, T., Hulse, R.P., Dersch, R., Lehrling, C., Bevan, H., Qiu, Y., Lagrèze, W.A., Wynick, D., et al.. (2013). VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro. Am. J. Pathol. 183: 918–929, https://doi.org/10.1016/j.ajpath.2013.05.031.Search in Google Scholar PubMed PubMed Central

Bernal-Bello, D., Jaenes-Barrios, B., Morales-Ortega, A., Ruiz-Giardin, J.M., García-Bermúdez, V., Frutos-Pérez, B., Farfán-Sedano, A.I., de Ancos-Aracil, C., Bermejo, F., and García-Gil, M. (2020). Imatinib might constitute a treatment option for lung involvement in COVID-19. Autoimmun. Rev. 218: 108518.10.1016/j.autrev.2020.102565Search in Google Scholar PubMed PubMed Central

Blanco-Melo, D., Nilsson-Payant, B., Liu, W.-C., Møller, R., Panis, M., Sachs, D., and Albrecht, R. (2020). SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems. Cell. 181(5): 1036–1045, doi:10.1016/j.cell.2020.04.026. 32416070.10.1101/2020.03.24.004655Search in Google Scholar PubMed

Brea, D., Sobrino, T., Rodríguez-Yáñez, M., Ramos-Cabrer, P., Agulla, J., Rodríguez-González, R., Campos, F., Blanco, M., and Castillo, J. (2011). Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke. Clin. Immunol. 139: 193–198, https://doi.org/10.1016/j.clim.2011.02.001.Search in Google Scholar PubMed

Cabler, S., French, A., and Orvedahl, A. (2020). A cytokine circus with a viral ringleader: SARS-CoV-2-associated cytokine storm syndromes. Trends Mol. Med. 26: 1078–1085, https://doi.org/10.1016/j.molmed.2020.09.012.Search in Google Scholar PubMed PubMed Central

Cameron, M.J., Ran, L., Xu, L., Danesh, A., Bermejo-Martin, J.F., Cameron, C.M., Muller, M.P., Gold, W.L., Richardson, S.E., Poutanen, S.M., et al.. (2007). Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J. Virol. 81: 8692–8706, https://doi.org/10.1128/jvi.00527-07.Search in Google Scholar PubMed PubMed Central

Cantuti-Castelvetri, L., Ojha, R., Pedro, L.D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al.. (2020). Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370: 856–860, https://doi.org/10.1126/science.abd2985.Search in Google Scholar PubMed PubMed Central

Carboni, S., Aboul-Enein, F., Waltzinger, C., Killeen, N., Lassmann, H., and Peña-Rossi, C. (2003). CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis. J. Neuroimmunol. 145: 1–11.https://doi.org/10.1016/j.jneuroim.2003.07.001.Search in Google Scholar PubMed

Cardona, G.C., Pájaro, L.D.Q., Marzola, I.D.Q., Villegas, Y.R., and Salazar, L.R.M. (2020). Neurotropism of SARS-CoV 2: mechanisms and manifestations. J. Neurol. Sci. 412: 116824, https://doi.org/10.1016/j.jns.2020.116824.Search in Google Scholar PubMed PubMed Central

Cariboni, A., Davidson, K., Dozio, E., Memi, F., Schwarz, Q., Stossi, F., Parnavelas, J.G., and Ruhrberg, C. (2011). VEGF signalling controls GnRH neuron survival via NRP1 independently of KDR and blood vessels. Development 138: 3723–3733, https://doi.org/10.1242/dev.063362.Search in Google Scholar PubMed PubMed Central

Cavalcante, P., Galbardi, B., Franzi, S., Marcuzzo, S., Barzago, C., Bonanno, S., Camera, G., Maggi, L., Kapetis, D., and Andreetta, F. (2016). Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein–Barr virus infection. Immunobiology 221: 516–527, https://doi.org/10.1016/j.imbio.2015.12.007.Search in Google Scholar PubMed

Che, Y., Qiu, J., Jin, T., Yin, F., Li, M., and Jiang, Y. (2016). Circulating memory T follicular helper subsets, Tfh2 and Tfh17, participate in the pathogenesis of Guillain–Barré syndrome. Sci. Rep. 6: 20963, https://doi.org/10.1038/srep20963.Search in Google Scholar PubMed PubMed Central

Chen, P., Yan, Q., Wang, S., Wang, C., and Zhao, P. (2016). Transfer of three transcription factors via a lentiviral vector ameliorates spatial learning and memory impairment in a mouse model of Alzheimer’s disease. Gene 587: 59–63, https://doi.org/10.1016/j.gene.2016.04.032.Search in Google Scholar PubMed

Chen, W. (2020). A potential treatment of COVID-19 with TGF-β blockade. Int. J. Biol. Sci. 16: 1954–1955, https://doi.org/10.7150/ijbs.46891.Search in Google Scholar PubMed PubMed Central

Cheng, Y., Wong, R., Soo, Y., Wong, W., Lee, C., Ng, M., Chan, P., Wong, K., Leung, C., and Cheng, G. (2005). Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur. J. Clin. Microbiol. Infect. Dis. 24: 44–46, https://doi.org/10.1007/s10096-004-1271-9.Search in Google Scholar PubMed PubMed Central

Colotta, F., Re, F., Polentarutti, N., Sozzani, S., and Mantovani, A. (1992). Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80: 2012–2020, https://doi.org/10.1182/blood.v80.8.2012.2012.Search in Google Scholar

Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N., and Decroly, E. (2020). The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 176: 104742, https://doi.org/10.1016/j.antiviral.2020.104742.Search in Google Scholar PubMed PubMed Central

Cronstein, B.N., Molad, Y., Reibman, J., Balakhane, E., Levin, R.I., and Weissmann, G. (1995). Colchicine alters the quantitative and qualitative display of selections on endothelial cells and neutrophils. J. Clin. Invest. 96: 994–1002, https://doi.org/10.1172/jci118147.Search in Google Scholar PubMed PubMed Central

Csencsits-Smith, K., Suescun, J., Li, K., Luo, S., Bick, D.L., and Schiess, M. (2016). Serum lymphocyte-associated cytokine concentrations change more rapidly over time in multiple system atrophy compared to Parkinson disease. Neuroimmunomodulation 23: 301–308, https://doi.org/10.1159/000460297.Search in Google Scholar

Cuervo, N.Z. and Grandvaux, N. (2020). ACE2: evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. Elife 9: e61390, https://doi.org/10.7554/eLife.61390.Search in Google Scholar

Cufi, P., Dragin, N., Weiss, J.M., Martinez‐Martinez, P., De Baets, M.H., Roussin, R., Fadel, E., Berrih‐Aknin, S., and Le Panse, R. (2013). Implication of double‐stranded RNA signaling in the etiology of autoimmune myasthenia gravis. Ann. Neurol. 73: 281–293, https://doi.org/10.1002/ana.23791.Search in Google Scholar

Čulić, O., Eraković, V., Čepelak, I., Barišić, K., Brajša, K., Ferenčić, Ž., Galović, R., Glojnarić, I., Manojlović, Z., Munić, V., et al.. (2002). Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur. J. Pharmacol. 450: 277–289.10.1016/S0014-2999(02)02042-3Search in Google Scholar

Daly, J.L., Simonetti, B., Klein, K., Chen, K.-E., Williamson, M.K., Antón-Plágaro, C., Shoemark, D.K., Simón-Gracia, L., Bauer, M., Hollandi, R., et al.. (2020). Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370: 861–865, https://doi.org/10.1126/science.abd3072.Search in Google Scholar PubMed

Davies, J., Randeva, H.S., Chatha, K., Hall, M., Spandidos, D.A., Karteris, E., and Kyrou, I. (2020). Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol. Med. Rep. 22: 4221–4226, https://doi.org/10.3892/mmr.2020.11510.Search in Google Scholar PubMed PubMed Central

De Rivero Vaccari, J.P., Brand, F.J., Sedaghat, C., Mash, D.C., Dietrich, W.D., and Keane, R.W. (2014). RIG-1 Receptor expression in the pathology of Alzheimer’s disease. J. Neuroinflammation 11: 67, https://doi.org/10.1186/1742-2094-11-67.Search in Google Scholar PubMed PubMed Central

De Virgiliis, F. and Di Giovanni, S. (2020). Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19. Nat. Rev. Neurol. 16: 645–652.10.1038/s41582-020-0402-ySearch in Google Scholar PubMed PubMed Central

Deng, L., Pan, J., Peng, Q., Dong, Z., and Wang, Y. (2017). Toll-like receptor 3 and interferon β mRNA expressions were increased in peripheral blood of ischemic stroke patients with good outcome. J. Stroke Cerebrovasc. Dis. 26: 559–566, https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.11.122.Search in Google Scholar PubMed

Derkow, K., Bauer, J.M., Hecker, M., Paap, B.K., Thamilarasan, M., Koczan, D., Schott, E., Deuschle, K., Bellmann-Strobl, J., Paul, F., et al.. (2013). Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells. PLoS One 8: e70626, https://doi.org/10.1371/journal.pone.0070626.Search in Google Scholar PubMed PubMed Central

Desideri, G., Cipollone, F., Necozione, S., Marini, C., Lechiara, M.C., Taglieri, G., Zuliani, G., Fellin, R., Mezzetti, A., Di Orio, F., et al.. (2008). Enhanced soluble CD40 ligand and Alzheimer’s disease: evidence of a possible pathogenetic role. Neurobiol. Aging 29: 348–356, https://doi.org/10.1016/j.neurobiolaging.2006.10.019.Search in Google Scholar PubMed

Diaz, J.H. (2020). Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J. Travel Med. 27, taaa041, https://doi.org/10.1093/jtm/taaa041.Search in Google Scholar PubMed PubMed Central

Didangelos, A. (2020). COVID-19 hyperinflammation: what about neutrophils?, mSphere. 5: e00367–e00320. https://doi.org/10.1128/mSphere.00367-20.Search in Google Scholar PubMed PubMed Central

Dumond, A., Brachet, E., Durivault, J., Vial, V., Puszko, A.K., Lepelletier, Y., Montemagno, C., Pagnuzzi-Boncompagni, M., Hermine, O., Garbay, C., et al.. (2021). Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma. J. Exp. Clin. Cancer Res. 40: 1–18, https://doi.org/10.1186/s13046-021-01832-x.Search in Google Scholar PubMed PubMed Central

Durante, M.A., Kurtenbach, S., Sargi, Z.B., Harbour, J.W., Choi, R., Kurtenbach, S., Goss, G.M., Matsunami, H., and Goldstein, B.J. (2020). Single-cell analysis of olfactory neurogenesis and differentiation in adult humans. Nat. Neurosci. 23: 323–326, https://doi.org/10.1038/s41593-020-0587-9.Search in Google Scholar PubMed PubMed Central

Fajgenbaum, D.C. and June, C.H. (2020). Cytokine storm. N. Engl. J. Med. 383: 2255–2273, https://doi.org/10.1056/nejmra2026131.Search in Google Scholar

Famous, K.R., Delucchi, K., Ware, L.B., Kangelaris, K.N., Liu, K.D., Thompson, B.T., and Calfee, C.S. (2017). Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am. J. Respir. Crit. Care Med. 195: 331–338, https://doi.org/10.1164/rccm.201603-0645oc.Search in Google Scholar

Fazzini, E., Fleming, J., and Fahn, S. (1992). Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson’s disease. Mov. Disord. 7: 153–158, https://doi.org/10.1002/mds.870070210.Search in Google Scholar PubMed PubMed Central

Felderhoff-Mueser, U., Herold, R., Hochhaus, F., Koehne, P., Ring-Mrozik, E., Obladen, M., and Buhrer, C. (2001). Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus. Arch. Dis. Child. 84: 369–372, https://doi.org/10.1136/adc.84.4.369.Search in Google Scholar PubMed PubMed Central

Geleijns, K., Laman, J.D., van Rijs, W., Tio-Gillen, A.P., Hintzen, R.Q., van Doorn, P.A., and Jacobs, B.C. (2005). Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain–Barré syndrome. J. Neuroimmunol. 161: 183–189, https://doi.org/10.1016/j.jneuroim.2004.12.001.Search in Google Scholar PubMed

Ghode, S.S., Bajaj, M.S., Kulkarni, R.S., Limaye, L.S., Shouche, Y.S., and Kale, V.P. (2017). Neuropilin-1 is an important niche component and exerts context-dependent effects on hematopoietic stem cells. Stem Cell. Dev. 26: 35–48, https://doi.org/10.1089/scd.2016.0096.Search in Google Scholar

González-Nicolás, M.Á., González-Guerrero, C., Pérez-Fernández, V.A., and Lázaro, A. (2020). Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm. Clin. Kidney J. 13: 903–905, https://doi.org/10.1093/ckj/sfaa193.Search in Google Scholar

Gralinski, L.E., Sheahan, T.P., Morrison, T.E., Menachery, V.D., Jensen, K., Leist, S.R., Whitmore, A., Heise, M.T., and Baric, R.S. (2018). Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio 9: e01753–18, https://doi.org/10.1128/mBio.01753-18.Search in Google Scholar

Guo, H.-F. and Vander Kooi, C.W. (2015). Neuropilin functions as an essential cell surface receptor. J. Biol. Chem. 290: 29120–29126, https://doi.org/10.1074/jbc.r115.687327.Search in Google Scholar

Guo, J., Huang, Z., Lin, L., and Lv, J. (2020). Coronavirus disease 2019 (COVID‐19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J. Am. Heart Assoc. 9: e016219, https://doi.org/10.1161/JAHA.120.016219.Search in Google Scholar

Gutierrez, E.G., Banks, W.A., and Kastin, A.J. (1993). Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47: 169–176, https://doi.org/10.1016/0165-5728(93)90027-v.Search in Google Scholar

Haick, A.K., Rzepka, J.P., Brandon, E., Balemba, O.B., and Miura, T.A. (2014). Neutrophils are needed for an effective immune response against pulmonary rat coronavirus infection, but also contribute to pathology. J. Gen. Virol. 95: 578–590, https://doi.org/10.1099/vir.0.061986-0.Search in Google Scholar PubMed PubMed Central

Hanchate, N.K., Giacobini, P., Lhuillier, P., Parkash, J., Espy, C., Fouveaut, C., Leroy, C., Baron, S., Campagne, C., Vanacker, C., et al.. (2012). SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome. PLoS Genet. 8: e1002896, https://doi.org/10.1371/journal.pgen.1002896.Search in Google Scholar PubMed PubMed Central

Herold, T., Jurinovic, V., Arnreich, C., Lipworth, B.J., Hellmuth, J.C., von Bergwelt-Baildon, M., Klein, M., and Weinberger, T. (2020). Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J. Allergy Clin. Immunol. 146: 128–136.e4, https://doi.org/10.1016/j.jaci.2020.05.008.Search in Google Scholar PubMed PubMed Central

Hintzen, R.Q., Paty, D., and Oger, J. (1999). Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 66: 791–793, https://doi.org/10.1136/jnnp.66.6.791.Search in Google Scholar PubMed PubMed Central

Hirano, T. and Murakami, M. (2020). COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity 52: 731–733, https://doi.org/10.1016/j.immuni.2020.04.003.Search in Google Scholar

Hopkins, C., Lechien, J.R., and Saussez, S. (2021). More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med. Hypotheses 146: 110406, https://doi.org/10.1016/j.mehy.2020.110406.Search in Google Scholar

Huang, K.J., Su, I.J., Theron, M., Wu, Y.C., Lai, S.K., Liu, C.C., and Lei, H.Y. (2005). An interferon‐γ‐related cytokine storm in SARS patients. J. Med. Virol. 75: 185–194, https://doi.org/10.1002/jmv.20255.Search in Google Scholar

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al.. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497–506, https://doi.org/10.1016/s0140-6736(20)30183-5.Search in Google Scholar

Hulse, R.P. (2017). Role of VEGF-A in chronic pain. Oncotarget 8: 10775, https://doi.org/10.18632/oncotarget.14615.Search in Google Scholar PubMed PubMed Central

Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al.. (2005). Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436: 112–116, https://doi.org/10.1038/nature03712.Search in Google Scholar PubMed PubMed Central

Isacson, O. (2020). The consequences of coronavirus-induced cytokine storm are associated with neurological diseases, which may be preventable. Front. Neurol. 11: 745, https://doi.org/10.3389/fneur.2020.00745.Search in Google Scholar PubMed PubMed Central

Jarvis, A., Allerston, C.K., Jia, H., Herzog, B., Garza-Garcia, A., Winfield, N., Ellard, K., Aqil, R., Lynch, R., Chapman, C., et al.. (2010). Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction. J. Med. Chem. 53: 2215–2226, https://doi.org/10.1021/jm901755g.Search in Google Scholar PubMed PubMed Central

Johnson, T.P., Tyagi, R., Patel, K., Schiess, N., Calabresi, P.A., and Nath, A. (2013). Impaired toll-like receptor 8 signaling in multiple sclerosis. J. Neuroinflammation 10: 1–4, https://doi.org/10.1186/1742-2094-10-74.Search in Google Scholar PubMed PubMed Central

Kielian, M. (2020). Enhancing host cell infection by SARS-CoV-2. Science 370: 765–766, https://doi.org/10.1126/science.abf0732.Search in Google Scholar PubMed

Kriszta, G., Kriszta, Z., Váncsa, S., Hegyi, P.J., Frim, L., Erőss, B., Hegyi, P., Pethő, G., and Pintér, E. (2021). Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on angiotensin-converting enzyme 2 levels: a comprehensive analysis based on animal studies. Front. Pharmacol. 12: 619524, https://doi.org/10.3389/fphar.2021.619524.Search in Google Scholar PubMed PubMed Central

Kyrou, I., Randeva, H.S., Spandidos, D.A., and Karteris, E. (2021). Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19. Signal. Transduct. Target. Ther. 6: 1–3, https://doi.org/10.1038/s41392-020-00460-9.Search in Google Scholar PubMed PubMed Central

Lamontagne, F., Agoritsas, T., Siemieniuk, R., Rochwerg, B., Bartoszko, J., Askie, L., Macdonald, H., Amin, W., Bausch, F.J., Burhan, E., et al.. (2021). A living WHO guideline on drugs to prevent COVID-19. BMJ 372: n526, https://doi.org/10.1136/bmj.n526.Search in Google Scholar PubMed

Landau, A.M., Luk, K.C., Jones, M.-L., Siegrist-Johnstone, R., Young, Y.K., Kouassi, E., Rymar, V.V., Dagher, A., Sadikot, A.F., and Desbarats, J. (2005). Defective Fas expression exacerbates neurotoxicity in a model of Parkinson’s disease. J. Exp. Med. 202: 575–581, https://doi.org/10.1084/jem.20050163.Search in Google Scholar PubMed PubMed Central

Lehmann, S.M., Krüger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., Trimbuch, T., Eom, G., Hinz, M., Kaul, D., et al.. (2012). An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15: 827–835, https://doi.org/10.1038/nn.3113.Search in Google Scholar PubMed

Li, Y., Zeng, Z., Cao, Y., Liu, Y., Ping, F., Liang, M., Xue, Y., Xi, C., Zhou, M., and Jiang, W. (2016). Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathways. Sci. Rep. 6: 27911, https://doi.org/10.1038/srep27911.Search in Google Scholar PubMed PubMed Central

Li, J., Sun, Y., and Chen, J. (2019). Transcriptome sequencing in a 6-hydroxydopamine rat model of Parkinson’s disease. Genes Genet. Syst. 94: 61–69, https://doi.org/10.1266/ggs.18-00036.Search in Google Scholar PubMed

Liu, B., Li, M., Zhou, Z., Guan, X., and Xiang, Y. (2020a). Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J. Autoimmun. 111: 102452, https://doi.org/10.1016/j.jaut.2020.102452.Search in Google Scholar PubMed PubMed Central

Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J., Feng, C., et al.. (2020b). Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci. China Life Sci. 63: 364–374, https://doi.org/10.1007/s11427-020-1643-8.Search in Google Scholar PubMed PubMed Central

Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al.. (2020). Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 26: 1200–1204, https://doi.org/10.1038/s41591-020-0965-6.Search in Google Scholar PubMed

Longping, V.T., Hamilton, A.M., Friling, T., and Whittaker, G.R. (2014). A novel activation mechanism of avian influenza virus H9N2 by furin. J. Virol. 88: 1673–1683, https://doi.org/10.1128/JVI.02648-13.Search in Google Scholar PubMed PubMed Central

Lopes, M.I., Bonjorno, L.P., Giannini, M.C., Amaral, N.B., Menezes, P.I., Dib, S.M., Gigante, S.L., Benatti, M.N., Rezek, U.C., Emrich-Filho, L.L., et al.. (2021). Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial. RMD Open 7: e001455, https://doi.org/10.1136/rmdopen-2020-001455.Search in Google Scholar PubMed PubMed Central

López, R.L., Fernández, S.C., Pérez, L.L., Palacios, A.R., Fernández-Roldán, M.C., Alonso, E.A., Camacho, I.P., Rodriguez-Baño, J., Merchante, N., Olalla, J., et al.. (2020). Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial. BMJ Open 10: e039951, https://doi.org/10.1136/bmjopen-2020-039951.Search in Google Scholar PubMed PubMed Central

Louapre, C., Collongues, N., Stankoff, B., Giannesini, C., Papeix, C., Bensa, C., Deschamps, R., Créange, A., Wahab, A., Pelletier, J., et al.. (2020). Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol. 77: 1079–1088, https://doi.org/10.1001/jamaneurol.2020.2581.Search in Google Scholar PubMed PubMed Central

Lu, Y., Liu, D.X., and Tam, J.P. (2008). Lipid rafts are involved in SARS-CoV entry into Vero E6 cells. Biochem. Biophys. Res. Commun. 369: 344–349, https://doi.org/10.1016/j.bbrc.2008.02.023.Search in Google Scholar PubMed PubMed Central

Ma, J., Ketkar, H., Geng, T., Lo, E., Wang, L., Xi, J., Sun, Q., Zhu, Z., Cui, Y., Yang, L., et al.. (2018). Zika virus non-structural protein 4A blocks the RLR-MAVS signaling. Front. Microbiol. 9: 1350, https://doi.org/10.3389/fmicb.2018.01350.Search in Google Scholar PubMed PubMed Central

Maes, B., Bosteels, C., De Leeuw, E., Declercq, J., Van Damme, K., Delporte, A., Demeyere, B., Vermeersch, S., Vuylsteke, M., Willaert, J., et al.. (2020). Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): a structured summary of a study protocol for a randomised controlled trial. Trials 21: 1–2, https://doi.org/10.1186/s13063-020-04453-5.Search in Google Scholar PubMed PubMed Central

Mahmudpour, M., Roozbeh, J., Keshavarz, M., Farrokhi, S., and Nabipour, I. (2020). COVID-19 cytokine storm: the anger of inflammation. Cytokine 133: 155151, https://doi.org/10.1016/j.cyto.2020.155151.Search in Google Scholar PubMed PubMed Central

Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al.. (2020a). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77: 683–690, https://doi.org/10.1001/jamaneurol.2020.1127.Search in Google Scholar PubMed PubMed Central

Mao, L.-L., Chen, W.-Y., Ma, A.-J., Ji, L.-L., and Huang, T.-T. (2020b). High serum OX40 ligand correlates with severity and mortality in patients with massive cerebral infarction. Medicine 99: e20883, https://doi.org/10.1097/md.0000000000020883.Search in Google Scholar PubMed PubMed Central

Margaryan, S., Witkowicz, A., Arakelyan, A., Partyka, A., Karabon, L., and Manukyan, G. (2018). sFasL-mediated induction of neutrophil activation in patients with type 2 diabetes mellitus. PLoS One 13: e0201087, https://doi.org/10.1371/journal.pone.0201087.Search in Google Scholar

Mattson, M.P. (1997). Neuroprotective signal transduction: relevance to stroke. Neurosci. Biobehav. Rev. 21: 193–206, https://doi.org/10.1016/s0149-7634(96)00010-3.Search in Google Scholar

McGonagle, D., Sharif, K., O’Regan, A., and Bridgewood, C. (2020). The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun. Rev. 19: 102537, https://doi.org/10.1016/j.autrev.2020.102537.Search in Google Scholar

Mehta, P., McAuley, D.F., Brown, M., Sanchez, E., Tattersall, R.S., and Manson, J.J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395: 1033–1034, https://doi.org/10.1016/s0140-6736(20)30628-0.Search in Google Scholar

Meng, J., Xiao, G., Zhang, J., He, X., Ou, M., Bi, J., Yang, R., Di, W., Wang, Z., and Li, Z. (2020). Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect 9: 757–760, https://doi.org/10.1080/22221751.2020.1746200.Search in Google Scholar PubMed PubMed Central

Merzon, E., Green, I., Vinker, S., Golan‐Cohen, A., Gorohovski, A., Avramovich, E., Frenkel‐Morgenstern, M., and Magen, E. (2021). The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection. FEBS J., https://doi.org/10.1111/febs.15784 (Epub ahead of print).Search in Google Scholar PubMed PubMed Central

Meshkat, S., Salimi, A., Joshaghanian, A., Sedighi, S., Sedighi, S., and Aghamollaii, V. (2020). Chronic neurological diseases and COVID-19: associations and considerations. Transl. Neurosci. 11: 294–301, https://doi.org/10.1515/tnsci-2020-0141.Search in Google Scholar PubMed PubMed Central

Middleton, E.A., He, X.-Y., Denorme, F., Campbell, R.A., Ng, D., Salvatore, S.P., Mostyka, M., Baxter-Stoltzfus, A., Borczuk, A.C., Loda, M., et al.. (2020). Neutrophil extracellular traps (NETs) contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136: 1169–1179, https://doi.org/10.1182/blood.2020007008.Search in Google Scholar PubMed PubMed Central

Mogi, M., Fukuo, K., Yang, J., Suhara, T., and Ogihara, T. (2001). Hypoxia stimulates release of the soluble form of fas ligand that inhibits endothelial cell apoptosis. Lab. Invest. 81: 177–184, https://doi.org/10.1038/labinvest.3780225.Search in Google Scholar PubMed

Moin, A.S.M., Sathyapalan, T., Atkin, S.L., and Butler, A.E. (2021). The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome. Metabol. Open 9: 100079, https://doi.org/10.1016/j.metop.2021.100079.Search in Google Scholar PubMed PubMed Central

Morales, D.R., Conover, M.M., You, S.C., Pratt, N., Kostka, K., Duarte-Salles, T., Fernández-Bertolín, S., Aragón, M., DuVall, S.L., et al.. (2021). Angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit. Health 3: e98–e114, https://doi.org/10.1016/s2589-7500(20)30289-2.Search in Google Scholar

Moussa, C., Hebron, M., Huang, X., Ahn, J., Rissman, R.A., Aisen, P.S., and Turner, R.S. (2017). Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease. J. Neuroinflammation 14: 1, https://doi.org/10.1186/s12974-016-0779-0.Search in Google Scholar PubMed PubMed Central

Moutal, A., Martin, L.F., Boinon, L., Gomez, K., Ran, D., Zhou, Y., Stratton, H.J., Cai, S., Luo, S., Gonzalez, K.B., et al.. (2021). SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia. Pain 162: 243–252, https://doi.org/10.1097/j.pain.0000000000002097.Search in Google Scholar PubMed PubMed Central

Nagata, S. and Golstein, P. (1995). The Fas death factor. Science 267: 1449–1456, https://doi.org/10.1126/science.7533326.Search in Google Scholar PubMed

Nakanishi, T., Fujita, Y., and Yamashita, T. (2019). Neuropilin-1-mediated pruning of corticospinal tract fibers is required for motor recovery after spinal cord injury. Cell Death Dis. 10: 1–11, https://doi.org/10.1038/s41419-019-1338-2.Search in Google Scholar PubMed PubMed Central

Netland, J., Meyerholz, D.K., Moore, S., Cassell, M., and Perlman, S. (2008). Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 82: 7264–7275, https://doi.org/10.1128/jvi.00737-08.Search in Google Scholar

Ottonello, L., Tortolina, G., Amelotti, M., and Dallegri, F. (1999). Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J. Immunol. 162: 3601–3606.10.4049/jimmunol.162.6.3601Search in Google Scholar

Pan, W., Xiang, S., Tu, H., and Kastin, A. (2006). Blood-brain barrier interfaces: from ontogeny to artificial barriers. Q. Rev. Biol. 81: 423.Search in Google Scholar

Peng, Y.-J., Peng, C.-T., Lin, Y.-H., Lin, G.-J., Huang, S.-H., Chen, S.-J., Sytwu, H.-K., and Cheng, C.-P. (2020). Decoy receptor 3 promotes preosteoclast cell death via reactive oxygen species-induced fas ligand expression and the IL-1α/IL-1 receptor antagonist pathway. Mediators Inflamm. 2020: 1237281, https://doi.org/10.1155/2020/1237281.Search in Google Scholar PubMed PubMed Central

Perez-Miller, S., Patek, M., Moutal, A., Duran, P., Cabel, C.R., Thorne, C.A., Campos, S.K., and Khanna, R. (2021). Novel compounds targeting neuropilin receptor 1 with potential to interfere with SARS-CoV-2 virus entry. ACS Chem. Neurosci. 12: 1299–1312, https://doi.org/10.1021/acschemneuro.0c00619.Search in Google Scholar PubMed PubMed Central

Pettit, N.N., MacKenzie, E.L., Ridgway, J.P., Pursell, K., Ash, D., Patel, B., and Pho, M.T. (2020). Obesity is associated with increased risk for mortality among hospitalized patients with COVID‐19. Obesity 28: 1806–1810, https://doi.org/10.1002/oby.22941.Search in Google Scholar PubMed PubMed Central

Powell, J., Mota, F., Steadman, D., Soudy, C., Miyauchi, J.T., Crosby, S., Jarvis, A., Reisinger, T., Winfield, N., Evans, G., et al.. (2018). Small molecule neuropilin-1 antagonists combine antiangiogenic and antitumor activity with immune modulation through reduction of transforming growth factor beta (TGFβ) production in regulatory T-cells. J. Med. Chem. 61: 4135–4154, https://doi.org/10.1021/acs.jmedchem.8b00210.Search in Google Scholar PubMed PubMed Central

Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., and Wang, W. (2020). Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 71 (15) : 762–768, https://doi.org/10.1093/cid/ciaa248.Search in Google Scholar

Rahmani, A., Baee, M., Saleki, K., Moradi, S., and Nouri, H.R. (2021). Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2. J. Biomol. Struct. Dyn.: 1–17, https://doi.org/10.1080/07391102.2021.1876774.Search in Google Scholar

Rahmani, A., Saleki, K., Javanmehr, N., Khodaparast, J., Saadat, P., and Nouri, H.R. (2020). Mesenchymal stem cell-derived extracellular vesicle-based therapies protect against coupled degeneration of the central nervous and vascular systems in stroke. Ageing Res. Rev. 62: 101106, https://doi.org/10.1016/j.arr.2020.101106.Search in Google Scholar

Raine, C., Bonetti, B., and Cannella, B. (1998). Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Rev. Neurol. 154: 577–585.Search in Google Scholar

Rasoulinejad, S.A., Karkhah, A., Paniri, A., Saleki, K., Pirzadeh, M., and Nouri, H.R. (2020). Contribution of inflammasome complex in inflammatory-related eye disorders and its implications for anti-inflammasome therapy. Immunopharmacol. Immunotoxicol. 42: 400–407, https://doi.org/10.1080/08923973.2020.1808986.Search in Google Scholar

Ray, P.R., Wangzhou, A., Ghneim, N., Yousuf, M.S., Paige, C., Tavares-Ferreira, D., Mwirigi, J.M., Shiers, S., Sankaranarayanan, I., McFarland, A.J., et al.. (2020). A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction. Brain Behav. Immun. 89: 559–568, https://doi.org/10.1016/j.bbi.2020.05.078.Search in Google Scholar

Reichard, R.R., Kashani, K.B., Boire, N.A., Constantopoulos, E., Guo, Y., and Lucchinetti, C.F. (2020). Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 140: 1–6, https://doi.org/10.1007/s00401-020-02166-2.Search in Google Scholar

Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., and Stebbing, J. (2020). Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 395: e30–e31, https://doi.org/10.1016/s0140-6736(20)30304-4.Search in Google Scholar

Ryabkova, V.A., Churilov, L.P., and Shoenfeld, Y. (2020). Influenza infection, SARS, MERS and COVID-19: cytokine storm–the common denominator and the lessons to be learned. Clin. Immunol. 223: 108652, https://doi.org/10.1016/j.clim.2020.108652.Search in Google Scholar PubMed PubMed Central

Salah, H.M. and Mehta, J.L. (2021). Meta-Analysis of the effect of aspirin on mortality in COVID-19. Am. J. Cardiol. 142: 158–159, https://doi.org/10.1016/j.amjcard.2020.12.073.Search in Google Scholar PubMed PubMed Central

Salehi, P., Ge, M.X., Gundimeda, U., Michelle Baum, L., Lael Cantu, H., Lavinsky, J., Tao, L., Myint, A., Cruz, C., and Wang, J. (2017). Role of neuropilin-1/semaphorin-3A signaling in the functional and morphological integrity of the cochlea. PLoS Genet. 13: e1007048, https://doi.org/10.1371/journal.pgen.1007048.Search in Google Scholar PubMed PubMed Central

Saleki, K., Banazadeh, M., Saghazadeh, A., and Rezaei, N. (2020). The involvement of the central nervous system in patients with COVID-19. Rev. Neurosci. 31: 453–456, https://doi.org/10.1515/revneuro-2020-0026.Search in Google Scholar PubMed

Saponaro, F., Rutigliano, G., Sestito, S., Bandini, L., Storti, B., Bizzarri, R., and Zucchi, R. (2020). ACE2 in the era of SARS-CoV-2: controversies and novel perspectives. Front. Mol. Biosci. 7: 588618, https://doi.org/10.3389/fmolb.2020.588618.Search in Google Scholar PubMed PubMed Central

Saresella, M., Gatti, A., Tortorella, P., Marventano, I., Piancone, F., La Rosa, F., Caputo, D., Rovaris, M., Biasin, M., and Clerici, M. (2014). Toll-like receptor 3 differently modulates inflammation in progressive or benign multiple sclerosis. Clin. Immunol. 150: 109–120, https://doi.org/10.1016/j.clim.2013.10.012.Search in Google Scholar PubMed

Saunders, J.A.H., Estes, K.A., Kosloski, L.M., Allen, H.E., Dempsey, K.M., Torres-Russotto, D.R., Meza, J.L., Santamaria, P.M., Bertoni, J.M., Murman, D.L., et al.. (2012). CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson’s disease. J. Neuroimmune Pharmacol. 7: 927–938, https://doi.org/10.1007/s11481-012-9402-z.Search in Google Scholar PubMed PubMed Central

Serrao, K.L., Fortenberry, J.D., Owens, M.L., Harris, F.L., and Brown, L.A.S. (2001). Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am. J. Physiol. Lung Cell Mol. Physiol. 280: L298–L305, https://doi.org/10.1152/ajplung.2001.280.2.l298.Search in Google Scholar

Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al.. (2020). Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. J. Am. Med. Assoc. 323: 1582–1589, https://doi.org/10.1001/jama.2020.4783.Search in Google Scholar PubMed PubMed Central

Sherafat, A., Pfeiffer, F., Reiss, A.M., Wood, W.M., and Nishiyama, A. (2021). Microglial neuropilin-1 promotes oligodendrocyte expansion during development and remyelination by trans-activating platelet-derived growth factor receptor. Nat. Commun. 12: 1–17, https://doi.org/10.1038/s41467-021-22532-2.Search in Google Scholar PubMed PubMed Central

Siemieniuk, R.A., Bartoszko, J.J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Rochwerg, B., Lamontagne, F., Han, M.A., et al.. (2020a). Drug treatments for COVID-19: living systematic review and network meta-analysis. BMJ 370: m2980, https://doi.org/10.1136/bmj.m2980.Search in Google Scholar PubMed PubMed Central

Siemieniuk, R. A. C., Bartoszko, J.J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Qasim, A., Martinez, J. P. D., and Rochwerg, B. (2020b). Update to living systematic review on drug treatments for COVID-19. Br. Med. J. 370: m3536.Search in Google Scholar

Siemieniuk, R. A. C., Bartoszko, J.J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Qasim, A., Martinez, J. P. D., and Rochwerg, B. (2020c). Update to living systematic review on drug treatments for COVID-19. Br. Med. J. 371: m4852.Search in Google Scholar

Siemieniuk, R. A. C., Bartoszko, J.J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Qasim, A., Martinez, J. P. D., and Rochwerg, B. (2021a). Update to living systematic review on drug treatments for COVID-19. Br. Med. J. 372: n858.Search in Google Scholar

Siemieniuk, RA, Bartoszko, J.J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Rochwerg, B., Lamontagne, F., Han, M.H., et al.. (2021b). Drug treatments for COVID-19: living systematic review and network meta-analysis. BMJ. 373: n967.10.1136/bmj.m2980Search in Google Scholar

Sinha, P., Delucchi, K.L., Thompson, B.T., McAuley, D.F., Matthay, M.A., and Calfee, C.S. (2018). Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med. 44: 1859–1869, https://doi.org/10.1007/s00134-018-5378-3.Search in Google Scholar PubMed PubMed Central

Sinha, P., Matthay, M.A., and Calfee, C.S. (2020). Is a “cytokine storm” relevant to COVID-19? JAMA Intern. Med. 180: 1152–1154, https://doi.org/10.1001/jamainternmed.2020.3313.Search in Google Scholar

Skipper, C.P., Pastick, K.A., Engen, N.W., Bangdiwala, A.S., Abassi, M., Lofgren, S.M., Williams, D.A., Okafor, E.C., Pullen, M.F., Nicol, M.R., et al.. (2020). Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial. Ann. Intern. Med. 173: 623–631, https://doi.org/10.7326/m20-4207.Search in Google Scholar

Soker, S., Takashima, S., Miao, H.Q., Neufeld, G., and Klagsbrun, M. (1998). Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735–745, https://doi.org/10.1016/s0092-8674(00)81402-6.Search in Google Scholar

Spray, D.C., Dermietzel, R., and Nedergaard, M. (2006). Blood-brain barriers: from ontogeny to artificial interfaces, (2 volume set). Wiley, Hoboken, New Jersey, p. 1.10.1002/9783527611225Search in Google Scholar

Su, J.H., Anderson, A.J., Cribbs, D.H., Tu, C., Tong, L., Kesslack, P., and Cotman, C.W. (2003). Fas and Fas Ligand are associated with neuritic degeneration in the AD brain and participate in β-amyloid-induced neuronal death. Neurobiol. Dis. 12: 182–193.10.1016/S0969-9961(02)00019-0Search in Google Scholar

Suidan, G.L., Dickerson, J.W., Johnson, H.L., Chan, T.W., Pavelko, K.D., Pirko, I., Seroogy, K.B., and Johnson, A.J. (2012). Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability. J. Neuroinflammation 9: 218.10.1186/1742-2094-9-218Search in Google Scholar PubMed PubMed Central

Suzuki, Y., Nakano, Y., Mishiro, K., Takagi, T., Tsuruma, K., Nakamura, M., Yoshimura, S., Shimazawa, M., and Hara, H. (2013). Involvement of Mincle and Syk in the changes to innate immunity after ischemic stroke. Sci. Rep. 3: 1–7.10.1038/srep03177Search in Google Scholar PubMed PubMed Central

Tay, M.Z., Poh, C.M., Rénia, L., MacAry, P.A., and Ng, L.F. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20: 363–374.10.1038/s41577-020-0311-8Search in Google Scholar PubMed PubMed Central

Teesalu, T., Sugahara, K.N., Kotamraju, V.R., and Ruoslahti, E. (2009). C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc. Natl. Acad. Sci. U S A 106: 16157–16162.10.1073/pnas.0908201106Search in Google Scholar PubMed PubMed Central

Turner, A.J. (2015). ACE2 cell biology, regulation, and physiological functions. In: The protective arm of the renin angiotensin system (RAS). Elsevier, p. 185.10.1016/B978-0-12-801364-9.00025-0Search in Google Scholar

Tüzün, E., Scott, B.G., Goluszko, E., Higgs, S., and Christadoss, P. (2003). Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis. J. Immunol. 171: 3847–3854.10.4049/jimmunol.171.7.3847Search in Google Scholar PubMed

Varzari, A., Bruch, K., Deyneko, I.V., Chan, A., Epplen, J.T., and Hoffjan, S. (2014). Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients. J. Neuroimmunol. 277: 140–144.10.1016/j.jneuroim.2014.09.015Search in Google Scholar PubMed

Volpe, E., Sambucci, M., Battistini, L., and Borsellino, G. (2016). Fas–fas ligand: checkpoint of t cell functions in multiple sclerosis. Front. Immunol. 7: 382.10.3389/fimmu.2016.00382Search in Google Scholar PubMed PubMed Central

Walls, A.C., Park, Y.-J., Tortorici, M.A., Wall, A., McGuire, A.T., and Veesler, D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181: 281–292.10.1016/j.cell.2020.02.058Search in Google Scholar PubMed PubMed Central

Wang, L., Azad, N., Kongkaneramit, L., Chen, F., Lu, Y., Jiang, B.-H., and Rojanasakul, Y. (2008). The Fas death signaling pathway connecting reactive oxygen species generation and FLICE inhibitory protein down-regulation. J. Immunol. 180: 3072–3080.10.4049/jimmunol.180.5.3072Search in Google Scholar PubMed PubMed Central

Wang, Y.-Z., Liang, Q.-H., Ramkalawan, H., Wang, Y.-L., Yang, Y.-F., Zhou, W.-B., Tian, F.-F., Li, J., and Yang, H. (2012). Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain-Barré syndrome. Neuroimmunomodulation 19: 60–68.10.1159/000328200Search in Google Scholar PubMed

Wang, Y.-L., Tan, M.-S., Yu, J.-T., Zhang, W., Hu, N., Wang, H.-F., Jiang, T., and Tan, L. (2013a). Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer’s disease in Han Chinese. J. Neuroinflammation 10: 101.10.1186/1742-2094-10-101Search in Google Scholar PubMed PubMed Central

Wang, Y.-Z., Yan, M., Tian, F.-F., Zhang, J.-M., Liu, Q., Yang, H., Zhou, W.-B., and Li, J. (2013b). Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis. Inflammation 36: 121–130.10.1007/s10753-012-9526-6Search in Google Scholar PubMed

Wang, J., Liu, Y., Liu, Y., Zhu, K., and Xie, A. (2020). The association between TLR3 rs3775290 polymorphism and sporadic Parkinson’s disease in Chinese Han population. Neurosci. Lett. 728: 135005.10.1016/j.neulet.2020.135005Search in Google Scholar PubMed

Woolf, S.H., Chapman, D.A., Sabo, R.T., Weinberger, D.M., and Hill, L. (2020). Excess deaths from COVID-19 and other causes, March–April 2020. J. Am. Med. Assoc. 324: 510–513.10.1001/jama.2020.11787Search in Google Scholar PubMed PubMed Central

Wu, C., Chen, X., Cai, Y., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., Zhang, Y., et al.. (2020a). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 180: 934–943.10.1001/jamainternmed.2020.0994Search in Google Scholar

Wu, Z., Hu, R., Zhang, C., Ren, W., Yu, A., and Zhou, X. (2020b). Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients. Crit. Care 24: 1–3.10.1186/s13054-020-03015-0Search in Google Scholar

Xiaoyan, Z., Pirskanen, R., Malmstrom, V., and Lefvert, A. (2006). Expression of OX40 (CD134) on CD4+ T‐cells from patients with myasthenia gravis. Clin. Exp. Immunol. 143: 110–116.10.1111/j.1365-2249.2005.02955.xSearch in Google Scholar

Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al.. (2020a). Effective treatment of severe COVID-19 patients with tocilizumab. Proc. Natl. Acad. Sci. U S A 117: 10970–10975.10.1073/pnas.2005615117Search in Google Scholar

Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al.. (2020b). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8: 420–422.10.1016/S2213-2600(20)30076-XSearch in Google Scholar

Yao, X.H., Li, T.Y., He, Z.C., Ping, Y.F., Liu, H.W., Yu, S.C., Mou, H.M., Wang, L.H., Zhang, H.R., Fu, W.J., et al.. (2020). A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi 49: E009.Search in Google Scholar

Yaqinuddin, A. and Kashir, J. (2020). Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using monalizumab, cholroquine, and antiviral agents. Med. Hypotheses 140: 109777.10.1016/j.mehy.2020.109777Search in Google Scholar PubMed PubMed Central

Yasuhara, T., Shingo, T., and Date, I. (2004). The potential role of vascular endothelial growth factor in the central nervous system. Rev. Neurosci. 15: 293–307.10.1515/REVNEURO.2004.15.4.293Search in Google Scholar

Yazdanpanah, N., Saghazadeh, A., and Rezaei, N. (2020). Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev. Neurosci. 31: 691–701.10.1515/revneuro-2020-0039Search in Google Scholar PubMed

Yeh, E.A., Collins, A., Cohen, M.E., Duffner, P.K., and Faden, H. (2004). Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 113: e73–e76.10.1542/peds.113.1.e73Search in Google Scholar PubMed

Yilmaz, V., Oflazer, P., Aysal, F., Parman, Y.G., Direskeneli, H., Deymeer, F., and Saruhan-Direskeneli, G.B. (2015). Cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis. Autoimmunity 48: 201–207.10.3109/08916934.2014.992517Search in Google Scholar PubMed

Yongzhi, X. (2021). COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue. Emerg Microbes Infec. 10: 266–276.10.1080/22221751.2021.1884503Search in Google Scholar

Zanin, L., Saraceno, G., Panciani, P.P., Renisi, G., Signorini, L., Migliorati, K., and Fontanella, M.M. (2020). SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. 162: 1491–1494.10.1007/s00701-020-04374-xSearch in Google Scholar

Zelano, G., Lino, M., Evoli, A., Settesoldi, D., Batocchi, A.P., Torrente, I., and Tonali, P.A. (1998). Tumour necrosis factor β gene polymorphisms in myasthenia gravis. Eur. J. Immunogenet. 25: 403–408.10.1046/j.1365-2370.1998.00129.xSearch in Google Scholar

Zhang, H., Wang, Z., Liu, R., Qian, T., Liu, J., Wang, L., and Chu, Y. (2018). Reactive oxygen species stimulated pulmonary epithelial cells mediate the alveolar recruitment of FasL+ killer B cells in LPS‐induced acute lung injuries. J. Leukoc. Biol. 104: 1187–1198.10.1002/JLB.3A0218-075RSearch in Google Scholar

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al.. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395: 1054–1062.10.1016/S0140-6736(20)30566-3Search in Google Scholar

Zhou, Y., Fang, L., Peng, L., and Qiu, W. (2017). TLR9 and its signaling pathway in multiple sclerosis. J. Neurol. Sci. 373: 95–99.10.1016/j.jns.2016.12.027Search in Google Scholar PubMed

Zhu, K., Teng, J., Zhao, J., Liu, H., and Xie, A. (2016). Association of TLR9 polymorphisms with sporadic Parkinson’s disease in Chinese Han population. Int. J. Neurosci. 126: 612–616.10.3109/00207454.2015.1050591Search in Google Scholar PubMed